1-158563112-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001160325.2(OR6P1):c.493C>A(p.Gln165Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000844 in 1,551,624 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001160325.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR6P1 | NM_001160325.2 | c.493C>A | p.Gln165Lys | missense_variant | 3/3 | ENST00000641540.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR6P1 | ENST00000641540.1 | c.493C>A | p.Gln165Lys | missense_variant | 3/3 | NM_001160325.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000427 AC: 65AN: 152082Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000102 AC: 16AN: 156424Hom.: 0 AF XY: 0.0000484 AC XY: 4AN XY: 82714
GnomAD4 exome AF: 0.0000472 AC: 66AN: 1399424Hom.: 0 Cov.: 35 AF XY: 0.0000304 AC XY: 21AN XY: 690224
GnomAD4 genome AF: 0.000427 AC: 65AN: 152200Hom.: 0 Cov.: 32 AF XY: 0.000403 AC XY: 30AN XY: 74394
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 08, 2022 | The c.493C>A (p.Q165K) alteration is located in exon 1 (coding exon 1) of the OR6P1 gene. This alteration results from a C to A substitution at nucleotide position 493, causing the glutamine (Q) at amino acid position 165 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at